Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function.

Anna M Blom1, Bruno O Villoutreix, Björn Dahlbäck

  • 1Lund University Department of Clinical Chemistry, University Hospital Malmö, The Wallenberg Laboratory, S-205 02 Malmö, Sweden and INSERM U428, Université Paris V, Paris 75006, France. Anna.Blom@klkemi.mas.lu.se

The Journal of Biological Chemistry
|August 2, 2003
PubMed
Summary

C4b-binding protein (C4BP) mutants selectively lost cofactor activity for C4b and C3b cleavage. Despite normal binding, these mutants failed to induce conformational changes necessary for protease function, highlighting specific structural requirements for complement regulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malondialdehyde epitopes exposed on dying cells are potent modulators of complement activity and efferocytosis.

Journal of lipid research·2026
Same author

Type 2 and type 1 diabetes have opposing effects on the systemic murine complement alternative pathway.

iScience·2026
Same author

C4BP occludes the non-opsonic interaction of <i>Neisseria gonorrhoeae</i> with human neutrophil CEACAMs.

Infection and immunity·2026
Same author

COMP-PMEPA1 axis promotes epithelial-to-mesenchymal transition in breast cancer cells.

Molecular oncology·2026
Same author

C4BP occludes the non-opsonic interaction of <i>Neisseria gonorrhoeae</i> with human neutrophil CEACAMs.

bioRxiv : the preprint server for biology·2026
Same author

Nuclear cell-free DNA on the loose: an early warning signal of ischemia-reperfusion injury in kidney transplantation.

Frontiers in immunology·2026

Area of Science:

  • Immunology
  • Biochemistry
  • Molecular Biology

Background:

  • C4b-binding protein (C4BP) is a key regulator of complement activation, inhibiting all pathways.
  • C4BP functions as a cofactor for serine protease factor I (FI) in degrading complement factors C4b and C3b.
  • C4BP structure involves alpha-chains (8 complement control protein domains) and a beta-chain (3 CCP domains).

Purpose of the Study:

  • To investigate the role of specific mutations in C4BP's alpha-chain CCP3 domain on its cofactor activity.
  • To determine if altered cofactor activity correlates with changes in C4b/C3b binding affinity or conformational changes.

Main Methods:

  • Site-directed mutagenesis to create C4BP mutants (K126Q/K128Q and F144S/F149S) in the alpha-chain CCP3 domain.
  • Surface plasmon resonance (SPR) to measure binding affinity of mutants to C4b/C3b.

Related Experiment Videos

  • Assays to assess cofactor activity in C4b and C3b cleavage and inhibitory effects on C3-convertase.

    • Main Results:

    • Two C4BP mutants (K126Q/K128Q and F144S/F149S) selectively lost cofactor activity for C4b and C3b cleavage.
    • These mutants exhibited normal binding affinity for C4b/C3b and similar inhibitory effects on C3-convertase as wild-type C4BP.
    • The data suggest that C4b and C3b do not undergo the same conformational changes upon binding to the mutants as with wild-type C4BP.

    Conclusions:

    • Specific residues within C4BP's alpha-chain CCP3 are critical for its cofactor function, independent of substrate binding affinity.
    • The loss of cofactor activity in mutants is attributed to impaired conformational changes in C4b/C3b upon binding.
    • These findings elucidate the mechanism of C4BP-mediated complement regulation and identify key structural determinants for cofactor activity.